Structures by: An H. Y.
Total: 9
C19H11NO3
C19H11NO3
Organic & biomolecular chemistry (2006) 4, 1 33-35
a=9.5260(19)Å b=18.319(4)Å c=7.9420(16)Å
α=90.00° β=96.25(3)° γ=90.00°
C19H13Cl2NO3
C19H13Cl2NO3
Organic & biomolecular chemistry (2006) 4, 1 33-35
a=12.895(3)Å b=9.910(2)Å c=13.175(3)Å
α=90.00° β=90.54(3)° γ=90.00°
C26H14CuN4O5
C26H14CuN4O5
Dalton Transactions (2009) 44 9807-9811
a=11.624(2)Å b=11.624(2)Å c=30.720(8)Å
α=90.00° β=90.00° γ=90.00°
C26H14CoN4O5
C26H14CoN4O5
Dalton Transactions (2009) 44 9807-9811
a=11.6004(13)Å b=11.6004(13)Å c=31.419(5)Å
α=90.00° β=90.00° γ=90.00°
C10H6.5InO9.75
C10H6.5InO9.75
Dalton transactions (Cambridge, England : 2003) (2011) 40, 36 9154-9158
a=9.038(2)Å b=9.038(2)Å c=18.975(10)Å
α=90.00° β=90.00° γ=120.00°
3-Benzoylmethyl-2-chloro-N-methylmaleimide
C13H10ClNO3
Acta Crystallographica Section E (2006) 62, 1 o70-o71
a=5.474(2)Å b=24.185(3)Å c=9.283(2)Å
α=90.00° β=98.78(3)° γ=90.00°
C26H24FN3O10Zn
C26H24FN3O10Zn
Crystal Growth & Design (2007) 7, 3 506
a=12.4906(13)Å b=12.3673(13)Å c=16.6196(17)Å
α=90.00° β=100.954(2)° γ=90.00°
C50H42F2N6O15Zn2
C50H42F2N6O15Zn2
Crystal Growth & Design (2007) 7, 3 506
a=25.300(5)Å b=10.910(2)Å c=19.079(4)Å
α=90.00° β=120.79(3)° γ=90.00°
C51H50F2N6O19Zn2
C51H50F2N6O19Zn2
Crystal Growth & Design (2007) 7, 3 506
a=24.763(5)Å b=12.380(3)Å c=17.729(4)Å
α=90.00° β=113.20(3)° γ=90.00°